LONSARIS Trademark

Trademark Overview

On Thursday, November 12, 2015, a trademark application was filed for LONSARIS with the United States Patent and Trademark Office. The USPTO has given the LONSARIS trademark a serial number of 86817594. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 23, 2019. This trademark is owned by Alkermes Pharma Ireland Limited. The LONSARIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases
lonsaris

General Information

Serial Number86817594
Word MarkLONSARIS
Filing DateThursday, November 12, 2015
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 23, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 27, 2016

Trademark Statements

Goods and ServicesPharmaceuticals, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases; Pharmaceutical compounds, namely, prodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorders, psychiatric and neurodegenerative diseases, cardiovascular diseases and metabolic diseases
Translation of Words in MarkThe wording "LONSARIS" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 17, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlkermes Pharma Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDublin 4
IE
Party NameAlkermes Pharma Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDublin 4
IE

Trademark Events

Event DateEvent Description
Monday, December 23, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 23, 2019ABANDONMENT - NO USE STATEMENT FILED
Thursday, May 9, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 8, 2019EXTENSION 5 GRANTED
Thursday, May 2, 2019EXTENSION 5 FILED
Wednesday, May 8, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, May 2, 2019TEAS EXTENSION RECEIVED
Tuesday, September 4, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 31, 2018EXTENSION 4 GRANTED
Friday, August 31, 2018EXTENSION 4 FILED
Friday, August 31, 2018TEAS EXTENSION RECEIVED
Thursday, March 29, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 27, 2018EXTENSION 3 GRANTED
Tuesday, March 27, 2018EXTENSION 3 FILED
Tuesday, March 27, 2018TEAS EXTENSION RECEIVED
Friday, October 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 18, 2017EXTENSION 2 GRANTED
Wednesday, October 18, 2017EXTENSION 2 FILED
Wednesday, October 18, 2017TEAS EXTENSION RECEIVED
Friday, April 28, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 26, 2017EXTENSION 1 GRANTED
Wednesday, April 26, 2017EXTENSION 1 FILED
Wednesday, April 26, 2017TEAS EXTENSION RECEIVED
Tuesday, November 22, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 27, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 27, 2016PUBLISHED FOR OPPOSITION
Wednesday, September 7, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 19, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 17, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 16, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 16, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 16, 2016ASSIGNED TO LIE
Tuesday, August 9, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, March 15, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 15, 2016NON-FINAL ACTION E-MAILED
Tuesday, March 15, 2016NON-FINAL ACTION WRITTEN
Monday, March 7, 2016ASSIGNED TO EXAMINER
Tuesday, November 17, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 16, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

lonsaris diseases disorders system psychiatric neurodegenerative metabolic cardiovascular nervous central chemical